These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Speroff L Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199 [TBL] [Abstract][Full Text] [Related]
3. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM; Naftolin F; Brinton EA; Judelson DR Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [TBL] [Abstract][Full Text] [Related]
4. An update on menopausal hormone replacement therapy in women and cardiovascular disease. Valdiviezo C; Lawson S; Ouyang P Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240 [TBL] [Abstract][Full Text] [Related]
5. [Hormone replacement therapy and cardiovascular risk]. Maffei S; De Caterina R G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173 [TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women. Al-Farra HM; Al-Fahoum SK; Tabbaa MA Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775 [TBL] [Abstract][Full Text] [Related]
8. Menopause and stroke and the effects of hormonal therapy. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and cardiovascular health in the United States. Shetty KD; Vogt WB; Bhattacharya J Med Care; 2009 May; 47(5):600-6. PubMed ID: 19319001 [TBL] [Abstract][Full Text] [Related]
10. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat. Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153 [TBL] [Abstract][Full Text] [Related]
11. Should observational studies be a thing of the past? Pritchard KI J Natl Cancer Inst; 2008 Apr; 100(7):451-2. PubMed ID: 18364499 [No Abstract] [Full Text] [Related]
13. Estrogen and stroke: a case for low-dose estrogen. Birge SS Menopause; 2006; 13(5):719-20. PubMed ID: 16932238 [No Abstract] [Full Text] [Related]
14. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies. Shapiro S Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373 [TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years. Dören M Maturitas; 2007 Aug; 57(4):422. PubMed ID: 17532152 [No Abstract] [Full Text] [Related]
16. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts]. Motolese M Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283 [TBL] [Abstract][Full Text] [Related]
19. [Hormone replacement therapy and the cardiovascular system: on the role of hemostasis]. Winkler UH Zentralbl Gynakol; 1995; 117(10):510-5. PubMed ID: 7491833 [TBL] [Abstract][Full Text] [Related]
20. Primary prevention of cardiovascular disease with hormone replacement therapy. Schierbeck L Climacteric; 2015; 18(4):492-7. PubMed ID: 25830825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]